2019
DOI: 10.1007/s13300-019-0571-0
|View full text |Cite
|
Sign up to set email alerts
|

Real-Time Sharing and Following of Continuous Glucose Monitoring Data in Youth

Abstract: Background Those caring for children and adolescents with diabetes often use glucose concentration and trending information in management decisions. Some continuous glucose monitoring (CGM) systems offer real-time sharing and monitoring capabilities through mobile apps carried by the person with diabetes and the caregiver(s), respectively. Few large studies have explored real-world associations between sharing and following, CGM utilization, and glycemic outcomes. Methods … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
21
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 36 publications
(23 citation statements)
references
References 11 publications
2
21
0
Order By: Relevance
“…The number of Dexcom Followers was the strongest predictor for reducing TBR suggesting that this functionality is protective. Our data is similar to the assessment of over 25,000 users that showed Dexcom Followers was associated with less TBR 40 . With the option of up to five followers when using the Dexcom G6 mobile app, it is advisable to promote appropriate followers.…”
Section: Discussionsupporting
confidence: 82%
“…The number of Dexcom Followers was the strongest predictor for reducing TBR suggesting that this functionality is protective. Our data is similar to the assessment of over 25,000 users that showed Dexcom Followers was associated with less TBR 40 . With the option of up to five followers when using the Dexcom G6 mobile app, it is advisable to promote appropriate followers.…”
Section: Discussionsupporting
confidence: 82%
“…In families, Share is often used by parents to monitor their young children; use of Share was associated with less hypoglycemia in youth in a large real-world study. 16 The Share feature also allows for use of CLARITY software by clinicians to remotely manage patients with new-onset T1D 17 or who are at high risk for diabetic ketosis and hyperglycemia. 18 In the hospital, several studies have described how remote monitoring with Share can be used to reduce inpatient hypoglycemia, 19 improve glucose management, 20 and potentially reduce the need for personal protective equipment in the setting of COVID-19.…”
Section: Conclusion/discussionmentioning
confidence: 99%
“…Data collected with CGM have also provided an important tool for testing the feasibility and effectiveness of insulin delivery systems, insulin treatments, adjunctive diabetes medications, T1D screening, new glucose monitoring systems, algorithms for the promotion of improved glycemic control, sensor-augmented therapy algorithms, and closed-loop systems ; diabetes alert dogs [92]; education programs aimed at improving impaired hypoglycemia unawareness, daily therapy decisions, and cardiovascular health [93][94][95]; and use of glucose sharing data with others [96]. This technology has also been used to assess the relationship between continuous glucose measures and other diabetes-related outcomes, including long-term glycemic control, dysglycemia [97,98], future T1D diagnosis or dysglycemia in preclinical youth [99][100][101], HbA 1c [102][103][104][105], C-peptide [102], insulin sensitivity [106], severe hypoglycemia [107], time in target range [108][109][110], glucose variability [109][110][111][112][113], detection of hypo-or hyperglycemia [108][109][110][114][115][116], glycated albumin [104], fructosamine [104], and 1,5-anhydroglucitrol [104].…”
Section: Using Cgm To Measure Outcomesmentioning
confidence: 99%